Investigation raises concerns about poor FDA oversight of clinical trials
New study discovers pre-treatment cognitive impairment in younger cancer patients
16 November 2022Investigation raises concerns about poor FDA oversight of clinical trials
16 November 2022Investigation raises concerns about poor FDA oversight of clinical trials
COVID-19 vaccines and drugs were developed at “warp speed” and now experts are concerned about the US Food and Drug Administration’s (FDA) inadequate surveillance of clinical trial sites, reports an investigation published by The BMJ today.
